Hematology (all articles)
Anticoagulation in COVID-19: A systematic review, meta-analysis and rapid guidance from the Mayo Clinic
1 Sep, 2020 | 06:26h | UTC
AGA Guidelines on the gastrointestinal evaluation of iron deficiency anemia
1 Sep, 2020 | 06:02h | UTC
[Abstract Only] Observational study: Therapeutic and prophylactic anticoagulation linked to lower in-hospital mortality in patients with Covid-19
27 Aug, 2020 | 09:51h | UTCCommentaries: Study provides more data on blood thinner efficacy for COVID-19 – The Mount Sinai Hospital AND Anticoagulants Associated With Better Survival, Lower Risk of Intubation in COVID-19 Patients
FDA issues emergency use authorization for convalescent plasma as potential COVID–19 treatment
25 Aug, 2020 | 03:58h | UTCCommentaries: Convalescent Plasma: The Science and the Politics – Science Translational Medicine AND Convalescent plasma: another controversial clash of politics & science – Health News Review AND Observational Study of Convalescent Plasma and FDA Response – datamethods AND FDA OKs use of convalescent plasma for COVID-1 – CIDRAP AND Is convalescent plasma safe and effective? We answer the major questions about the Covid-19 treatment – STAT
Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19
25 Aug, 2020 | 03:53h | UTC
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients
25 Aug, 2020 | 03:45h | UTC
Study suggests low risk of post-discharge venous thromboembolism following hospital admission with COVID-19
16 Aug, 2020 | 22:24h | UTCPost-discharge venous thromboembolism following hospital admission with COVID-19 – Blood
Commentary: Post-Hospital Venous Thromboembolism in Patients With COVID-19 – American College of Cardiology
Coagulopathy in COVID-19: Manifestations and management
14 Aug, 2020 | 01:21h | UTCCoagulopathy in COVID-19: Manifestations and management – Cleveland Clinic Journal of Medicine
[Preprint] Observational study: Effect of convalescent plasma on mortality among hospitalized patients with COVID-19
14 Aug, 2020 | 01:24h | UTCCommentary: Large study suggests convalescent plasma can help treat Covid-19, but experts have doubts – STAT
Commentary on Twitter
🔥 Preliminary results from convalescent plasma Expanded Access Program 🔥
35,322 patients 😯
Not an RCT 😞
But, lower mortality with earlier administration & higher antibody titre support possible efficacy 🧐https://t.co/xwzz3mQ0qX pic.twitter.com/Utquky4wW1
— Ilan Schwartz is on🦋 (@GermHunterMD) August 13, 2020
Systematic review: The use of erythropoietin plus iron to correct anemia before surgery to reduce the risk of blood transfusion
14 Aug, 2020 | 01:04h | UTC
[Abstract Only] Randomized trial: Liberal vs. restrictive transfusion thresholds in extremely low-birth-weight infants
14 Aug, 2020 | 01:06h | UTCCommentary: When should we transfuse preterm babies, and why? – Neonatal Research
Commentary on Twitter
Among extremely low-birth-weight infants, a liberal blood transfusion strategy did not reduce the likelihood of death or disability at 24 months compared with a restrictive strategy #VisualAbstract https://t.co/75YAhZx6au
— JAMA (@JAMA_current) August 12, 2020
Review: Investigation and management of erythrocytosis
14 Aug, 2020 | 01:02h | UTCInvestigation and management of erythrocytosis – Canadian Medical Association Journal
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
12 Aug, 2020 | 02:20h | UTCCommentary: New guidelines for managing mucositis now available – University of Rochester Medical Center
Peripheral blood examination findings in SARS-CoV-2 infection
10 Aug, 2020 | 01:58h | UTC
Study: Bleeding and thrombotic manifestations of SARS-CoV-2 infection
7 Aug, 2020 | 03:16h | UTCCOVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection – Blood
Invited commentary: COVID-19 coagulopathy, thrombosis, and bleeding – Blood
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
4 Aug, 2020 | 03:01h | UTCCommentary: Ancient part of immune system may underpin severe COVID – Columbia University Irving Medical Center
Commentary on Twitter
https://twitter.com/nresearchnews/status/1290308064185180160
Management and prevention of anemia (acute bleeding excluded) in adult critical care patients
23 Jul, 2020 | 08:21h | UTC
[Abstract Only] Randomized trial: Carfilzomib, dexamethasone, and daratumumab vs. carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma
22 Jul, 2020 | 02:11h | UTC
Thrombosis in hospitalized patients with COVID-19 in a New York City health system
21 Jul, 2020 | 09:21h | UTCThrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA
Hematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19
16 Jul, 2020 | 08:24h | UTCCommentary: Coagulation disorder in COVID-19 – The Lancet Haematology
Related Commentary on Twitter
NEW research—Results of a retrospective study including 380 patients with #COVID19 admitted to Wuhan Union Hospital explores haematological characteristics and related risk factors https://t.co/lbDVw5lFBC pic.twitter.com/0qlvHzfzhR
— The Lancet Haematology (@TheLancetHaem) July 11, 2020
ACC Consensus on management of anticoagulant-related bleeding
15 Jul, 2020 | 08:12h | UTCKey Points: ACC Consensus on Management of Anticoagulant-Related Bleeding
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19
13 Jul, 2020 | 00:13h | UTCCommentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane
Related Commentary on Twitter
https://twitter.com/CochraneUK/status/1281613914296516608
[Preprint] Randomized Trial: Convalescent Plasma for COVID-19
6 Jul, 2020 | 08:47h | UTCConvalescent Plasma for COVID-19. A randomized clinical trial – medRxiv
Related Commentary on Twitter
https://twitter.com/hildabast/status/1279625347214921729
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
30 Jun, 2020 | 07:41h | UTCCommentary: Researchers discover improved treatment for children with sickle cell anemia – Indiana University